Trial Profile
Long-term phase II trial of AMZ 0026 in patients with HIV-1 infections.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 20 Mar 2012
Price :
$35
*
At a glance
- Drugs AMZ 0026 (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 20 Mar 2012 New trial record